Table 2 Correlation between AGXT expression and clinicopathological features in 101 HCC patients
Variable | AGXT | P-value | |
|---|---|---|---|
Low (n = 41) | High and moderate (n = 60) | ||
Age | 0.277 | ||
 ≤ 50 | 16 | 30 |  |
 > 50 | 25 | 30 | |
Gender | 0.257 | ||
 Male | 28 | 47 |  |
 Female | 13 | 13 | |
HBsAg | 0.092 | ||
 Positive | 34 | 56 |  |
 Negative | 6 | 3 |  |
Portal vein tumor thrombus | 0.930 | ||
 No | 17 | 38 |  |
 Yes | 1 | 2 | |
Cirrhosis | 0.499 | ||
 Yes | 28 | 40 |  |
 No | 8 | 16 | |
Tumor number | 0.882 | ||
 Single | 13 | 31 |  |
 Multiple | 3 | 8 | |
Serum AFP (ng/ml) | 0.078 | ||
 ≤ 300 | 15 | 32 |  |
 > 300 | 17 | 16 | |
Vascular invasion | 0.984 | ||
 Yes | 17 | 25 |  |
 No | 24 | 35 | |
Tumour size (cm) | 0.955 | ||
 ≤ 3 | 19 | 27 |  |
 > 3 | 22 | 32 |  |
Tumor differentiation | < 0.0001* | ||
 Well | 0 | 20 |  |
 Moderate | 7 | 32 | |
 Poor | 34 | 8 | |
TNM | 0.720 | ||
 I | 18 | 25 |  |
 II | 17 | 24 | |
 III–IV | 3 | 6 | |